As the C language, which forms the basis of critical global software like operating systems, faces security limitations, ...

The Los Angeles Business Journal and PNC Bank proudly announce our new podcast series: PNC C-Speak®, the Language of Executives, a podcast created to amplify the forward-thinking business approaches ...

Effective monitoring of development aid is the foundation for assessing the alignment of flows with their intended ...

Recursion's approach is intriguing, as evidenced by the fact that several of the world's largest pharmaceutical companies ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious "techbio" company positions itself for its next phase of AI drug discovery.

With AI advancements upending the role of senior executives, the question is what the C-suite transformation should look like ...

Recursion Pharmaceuticals ( ($RXRX) ) has provided an update. Recursion Pharmaceuticals announced significant leadership changes effective January ...

Recursion Pharmaceuticals, Inc (($RXRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Recursion Pharmaceuticals, ...